Cassava hasn't received the scientific attention of cash crops such as wheat, but the seventh annual meeting of NextGen Cassava hopes to draw attention to the sub-Saharan Africa dietary staple.
ZYMtronix, a startup company with roots in Cornell-developed technology and operating in Cornell’s McGovern Center for business development, has signed an agreement with Codexis, a major producer of pharmaceutical enzymes.
Horticulture senior lecturer Marcia Eames-Sheavly's Seed to Supper two-semester course sequence exposes students to a deeper level of community building and engagement.
Cornell undergraduates joined 200,000 green advocates to parade down Washington's Pennsylvania Avenue for the Peoples Climate March April 29 – in sultry heat – to advocate for rescuing the world from environmental deterioration.
A survey of the national Physician Quality Reporting System that assesses the quality of patient care is more comprehensive than earlier iterations, but there is still room for improvement.
More than 200 Cornell undergraduate and graduate students joined 40,000 scientists and boosters to champion knowledge in the first March for Science in Washington, D.C., April 22.
Using white blood cells to ferry potent cancer-killing proteins through the bloodstream, Cornell researchers have confirmed a new way to kill metastatic cancer tumors.
Cardiologist Dr. Erica Jones started an internship at Weill Cornell Medicine in 1992 and never left. She directs the institution's Heart Health program.
A Cornell study finds consumers are supportive of labeling decisions when they believe the company considered the public’s input. It bolsters research into perceived fairness in decision-making.
A Weill Cornell Medical College study in Neurosurgery suggests that gender-specific genes and other epigenetic factors might influence the formation and development of pediatric brain cancers.